Product Description
Brand Mindray
Sample Type Serum
Pack Size 2 x 50T, 2 x 100T
CAT No 10500566800, 10500568500
Application Immuno-Assay
Ourchemiluminescence immunoassay reagentshave been specially developed to work with Mindray's CL series automatic chemiluminescence immunoassay analyzers to make a complete system, offering high reliability and accuracy. Mindray uses liquid, ready-to-use reagents which come in
High Sensitivity Oncology DiagnosticsMindray Cancer Antigen 72-4 (CLIA) delivers highly sensitive and specific results, making it a robust tool for clinical oncology. The advanced CLIA technology ensures accurate quantification of tumor markers from serum samples, enabling healthcare professionals to make informed diagnostic and treatment decisions quickly.
User-Friendly and Fast OperationThis kit is designed for streamlined laboratory workflow, with ready-to-use liquids, automatic operation, and an assay time of about 30 minutes. Its compatibility with Mindray CL-series analyzers further enhances convenience, reducing hands-on time and ensuring consistent, reliable performance.
Comprehensive, Ready-to-Use Kit ComponentsEach package contains the necessary reagents, calibrators, and controls for 50 tests, simplifying setup and minimizing preparation errors. The clear, transparent liquids, coupled with detailed instructions, enable professional users to maintain high accuracy and reproducibility in every run.
FAQ's of Mindray Cancer Antigen 72-4 (CLIA):
Q: How does the Mindray Cancer Antigen 72-4 (CLIA) kit work?
A: The kit uses a sandwich chemiluminescence immunoassay (CLIA) principle to detect and quantify CA72-4 antigens in serum samples. The process involves binding the antigen with specific antibodies, which then generate a chemiluminescent signal measured by Mindray CL-series analyzers.
Q: What types of samples are required for testing with this kit?
A: This kit is designed for use with serum samples obtained from human subjects. It is intended for professional laboratory use in clinical diagnostics, specifically for oncology applications.
Q: When should a laboratory use this kit?
A: The Mindray Cancer Antigen 72-4 (CLIA) kit is suitable for use during patient evaluation, monitoring, and follow-up in oncology settings where CA72-4 levels are relevant. Its fast assay time is advantageous when rapid results are needed for clinical decision-making.
Q: Where should the kit be stored to maintain stability and accuracy?
A: To ensure optimal performance, the kit must be kept refrigerated at temperatures between 2C and 8C. It should never be frozen and must remain sealed until use to preserve reagent quality.
Q: What is the process for running a test with the CA72-4 kit?
A: Simply load the ready-to-use reagents, calibrators, and controls into a compatible Mindray CL-series Immunoassay Analyzer, along with the serum sample. The system automates the assay, providing results in approximately 30 minutes.
Q: What are the primary benefits of using this kit in a laboratory setting?
A: The kit offers high sensitivity, quick result turnaround, reliable accuracy, and reproducible outcomes. It streamlines workflow due to its ready-to-use components and automatic operation, enhancing laboratory efficiency and supporting better patient care.
Q: Who is authorized to use the Mindray Cancer Antigen 72-4 (CLIA) kit?
A: Only trained laboratory professionals should operate this kit, as it is intended for professional use with automatic immunoassay equipment in clinical laboratory environments.